Mutations in the JAK/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas

Leukemia

Volumn 30, Issue 11, 2016, Pages 2245-2247

  Nicolae, A ^a   Xi, L ^a   Pham, T H ^a   Pham, T A ^a   Navarro, W ^a   Meeker, H G ^a   Pittaluga, S ^a   Jaffe, E S ^a   Raffeld, M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYTOKINE RECEPTOR; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 3; K RAS PROTEIN; N RAS PROTEIN; NOTCH1 RECEPTOR; PROTEIN KINASE FYN; PROTEIN KINASE TYK2; RAS PROTEIN; SIGNAL PEPTIDE; STAT PROTEIN; STAT3 PROTEIN; STAT5B PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR EZH2; TUMOR EXTRACT; UNCLASSIFIED DRUG; PROTEIN P21;

CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INTESTINE LYMPHOMA; LETTER; MOLECULAR PATHOLOGY; NEXT GENERATION SEQUENCING; ONCOGENE; PERIPHERAL T CELL LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC MUTATION; GENETICS; INTESTINE TUMOR; METABOLISM; MUTATION; T CELL LYMPHOMA;

HUMANS; INTESTINAL NEOPLASMS; JANUS KINASES; LYMPHOMA, T-CELL; MUTATION; ONCOGENE PROTEIN P21(RAS); SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84978112142     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2016.178     Document Type: Letter

References (13)

1. Delabie J, Holte H, Vose JM, Ullrich F, Jaffe ES, Savage KJ et al. Enteropathyassociated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 2011; 118: 148-155.
2. Chan JK, Chan AC, Cheuk W, Wan SK, Lee WK, Lui YH et al. Type II enteropathyassociated T-cell lymphoma: A distinct aggressive lymphoma with frequent gammadelta T-cell receptor expression. Am J Surg Pathol 2011; 35: 1557-1569.
3. Deleeuw RJ, Zettl A, Klinker E, Haralambieva E, Trottier M, Chari R et al. Wholegenome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 2007; 132: 1902-1911.
4. Tomita S, Kikuti YY, Carreras J, Kojima M, Ando K, Takasaki H et al. Genomic and immunohistochemical profiles of enteropathy-associated T-cell lymphoma in Japan. Mod Pathol 2015; 28: 1286-1296.
5. Kucuk C, Jiang B, Hu X, Zhang W, Chan JK, Xiao W et al. Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells. Nat Commun 2015; 6: 6025.
6. Nairismagi ML, Tan J, Lim JQ, Nagarajan S, Ng CC, Rajasegaran V et al. JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma. Leukemia 2016; 30: 1311-1319.
7. Attygalle AD, Cabecadas J, Gaulard P, Jaffe ES, de Jong D, Ko YH et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward-report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology 2014; 64: 171-199.
8. Crescenzo R, Abate F, Lasorsa E, Tabbo F, Gaudiano M, Chiesa N et al. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 2015; 27: 516-532.
9. Heneghan AF, Pierre JF, Kudsk KA. JAK-STAT and intestinal mucosal immunology. JakStat 2013; 2: e25530.
10. Nicolae A, Xi L, Pittaluga S, Abdullaev Z, Pack SD, Chen J et al. Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas. Leukemia 2014; 28: 2244-2248.
11. Jerez A, Clemente MJ, Makishima H, Koskela H, Leblanc F, Peng NgK et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood 2012; 120: 3048-3057.
12. Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmaki H, Andersson EI et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366: 1905-1913.
13. Koo GC, Tan SY, Tang T, Poon SL, Allen GE, Tan L et al. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov 2012; 2: 591-597.